专题：Complement system in diseases

This cluster of papers explores the role of the complement system in immune response, focusing on its involvement in thrombotic microangiopathies, hemolytic uremic syndrome, and inflammatory diseases. It delves into the genetics, regulation, and therapeutic interventions such as Eculizumab for managing complement-related disorders.
最新文献
Hemolytic Uremic Syndrome Outbreak in Adults and Shiga Toxin–Producing Escherichia coli Negative for Locus of Enterocyte Effacement, France, 2025

article Full Text OpenAlex

2025 Inborn errors of immunity practice parameter

article Full Text OpenAlex

Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletes

article Full Text OpenAlex

Intracellular complement Factor H promotes tumor progression through modulation of cell cycle and actin cytoskeleton

article Full Text OpenAlex

ST-Segment Elevation Myocardial Infarction Following Adalimumab Initiation in a Young Adult

article Full Text OpenAlex

CSF ‐Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery

article Full Text OpenAlex

Von Willebrand Factor at the Crossroads of Hemostasis and Inflammation

article Full Text OpenAlex

APOL1 plasma membrane pools resist rapid protein degradation

article Full Text OpenAlex

C3a-C3ar1 axis mediates macrophage M1 polarization to drive silicosis inflammation and fibrosis

article Full Text OpenAlex

The Complement System in ANCA‐Associated Vasculitis: Mechanistic Insights, Therapeutic Horizons, and Unmet Clinical Needs

article Full Text OpenAlex

近5年高被引文献
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

article Full Text OpenAlex 1427 FWCI139.3394

The roles of extracellular vesicles in the immune system

review Full Text OpenAlex 1140 FWCI90.2948

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue

article Full Text OpenAlex 555 FWCI87.7703

Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients

article Full Text OpenAlex 538 FWCI52.6306

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

article Full Text OpenAlex 385 FWCI56.1457

A guide to complement biology, pathology and therapeutic opportunity

review Full Text OpenAlex 254 FWCI40.2141

Complosome — the intracellular complement system

review Full Text OpenAlex 234 FWCI37.6421

Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis

article Full Text OpenAlex 210 FWCI23.0888

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection

review Full Text OpenAlex 207 FWCI19.5813

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

article Full Text OpenAlex 192 FWCI34.7845